Advertisement: TTP Killer 50
30 December, 2014 - 10:47 By News Desk

F-star

F-star, biopharma, antibodies, cambridge

Antibodies specialist F-star won the Life Science Innovation category, sponsored by AstraZeneca and MedImmune, at the March 2017 Business Weekly Awards.

F–star is a biopharmaceutical company focused on developing immuno-oncology bispecific antibody therapeutics. 

It is poised to dominate the bispecific antibody space in immuno-oncology through the application of highly efficient Modular Antibody Technology™ platform. This powerful platform enables the discovery of novel bispecific antibodies, which are selected for their potential to transform the treatment of cancer.

f-star.com

 

Newsletter Subscription

Stay informed of the latest news and features